Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing
|
March 15, 2001
Effect of different location of atrial lead position on nearfield and farfield electrograms in dual chamber pacemaker-defibrillators
B K Kantharia, S L Wilbur, F A Padder, et al.
Clinical Genetics
|
August 1, 1983
Atypical Down syndrome and partial trisomy 21
E C Jenkins, C J Duncan, C E Wright, et al.
Circulation
|
June 1, 1980
Atherosclerosis-related responses to cigarette smoking in the baboon
W R Rogers, R L Bass, D E Johnson, et al.
Science (New York, N.Y.)
|
September 1, 1995
Microlithography by using neutral metastable atoms and self-assembled monolayers
K K Berggren, A Bard, J L Wilbur, et al.
Journal of the American College of Cardiology
|
February 17, 2000
Efficacy and safety of catheter ablation in octogenarians
E S Zado, D J Callans, C D Gottlieb, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 14, 2021
mRNA vaccination compared to infection elicits an IgG-predominant response with greater SARS-CoV-2 specificity and similar decrease in variant spike recognition
Katharina Röltgen, Sandra C A Nielsen, Prabhu S Arunachalam, et al.
Journal of Medicinal Chemistry
|
December 14, 2017
Discovery of LY3104607: A Potent and Selective G Protein-Coupled Receptor 40 (GPR40) Agonist with Optimized Pharmacokinetic Properties to Support Once Daily Oral Treatment in Patients with Type 2 Diabetes Mellitus
Chafiq Hamdouchi, Pranab Maiti, Alan M Warshawsky, et al.
Nature Communications
|
April 27, 2018
Structural basis for GPR40 allosteric agonism and incretin stimulation
Joseph D Ho, Betty Chau, Logan Rodgers, et al.
Journal of Medicinal Chemistry
|
October 18, 2016
The Discovery, Preclinical, and Early Clinical Development of Potent and Selective GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus (LY2881835, LY2922083, and LY2922470)
Chafiq Hamdouchi, Steven D Kahl, Anjana Patel Lewis, et al.
Cell Host & Microbe
|
December 3, 2021
Direct comparison of antibody responses to four SARS-CoV-2 vaccines in Mongolia
Naranjargal J Dashdorj, Oliver F Wirz, Katharina Röltgen, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing
|
March 15, 2001
Effect of different location of atrial lead position on nearfield and farfield electrograms in dual chamber pacemaker-defibrillators
B K Kantharia, S L Wilbur, F A Padder, et al.
Clinical Genetics
|
August 1, 1983
Atypical Down syndrome and partial trisomy 21
E C Jenkins, C J Duncan, C E Wright, et al.
Circulation
|
June 1, 1980
Atherosclerosis-related responses to cigarette smoking in the baboon
W R Rogers, R L Bass, D E Johnson, et al.
Science (New York, N.Y.)
|
September 1, 1995
Microlithography by using neutral metastable atoms and self-assembled monolayers
K K Berggren, A Bard, J L Wilbur, et al.
Journal of the American College of Cardiology
|
February 17, 2000
Efficacy and safety of catheter ablation in octogenarians
E S Zado, D J Callans, C D Gottlieb, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 14, 2021
mRNA vaccination compared to infection elicits an IgG-predominant response with greater SARS-CoV-2 specificity and similar decrease in variant spike recognition
Katharina Röltgen, Sandra C A Nielsen, Prabhu S Arunachalam, et al.
Journal of Medicinal Chemistry
|
December 14, 2017
Discovery of LY3104607: A Potent and Selective G Protein-Coupled Receptor 40 (GPR40) Agonist with Optimized Pharmacokinetic Properties to Support Once Daily Oral Treatment in Patients with Type 2 Diabetes Mellitus
Chafiq Hamdouchi, Pranab Maiti, Alan M Warshawsky, et al.
Nature Communications
|
April 27, 2018
Structural basis for GPR40 allosteric agonism and incretin stimulation
Joseph D Ho, Betty Chau, Logan Rodgers, et al.
Journal of Medicinal Chemistry
|
October 18, 2016
The Discovery, Preclinical, and Early Clinical Development of Potent and Selective GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus (LY2881835, LY2922083, and LY2922470)
Chafiq Hamdouchi, Steven D Kahl, Anjana Patel Lewis, et al.
Cell Host & Microbe
|
December 3, 2021
Direct comparison of antibody responses to four SARS-CoV-2 vaccines in Mongolia
Naranjargal J Dashdorj, Oliver F Wirz, Katharina Röltgen, et al.
Page
of 5